How Recursion Is Using AI to Rethink Drug Discovery

In this episode, Ed is joined by Ben Taylor, Chief Financial Officer and President of Recursion UK, to discuss how AI is reshaping drug discovery, biotech, and the future of medicine. Ben explains how Recursion uses AI, lab automation, biological data, and machine learning to improve the way new medicines are discovered and developed. They explore why drug discovery has such a high failure rate,…